Medication therapy safety stewardship to improve the medication therapy safety
Completed
- Conditions
- drug therapy safetymedication erroradverse drug events
- Registration Number
- DRKS00017534
- Lead Sponsor
- ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
in-patient stay for at least 72h
- ability to give consent
- treatment in a ward of Fürth hospital which is part of the AMTS-Stewardship-Project
Exclusion Criteria
- incapable to give consent
- age under 18 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - improvement of detection and documentation of drug-related problems (i.e. adverse drug reaction and contraindicated prescriptions) <br>
- Secondary Outcome Measures
Name Time Method - improvement of the identification of medication-therapy-safety-high-risk-patients<br>- investigation of usage and acceptance of measurements to improve medication-therapy-safety
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does medication therapy safety stewardship in DRKS00017534 mitigate adverse drug events through pharmacovigilance frameworks?
What comparative effectiveness data exists for medication safety stewardship programs versus standard-of-care protocols in DRKS00017534?
Which biomarkers correlate with medication error risk in DRKS00017534's observational study of drug therapy safety?
What strategies for managing high-risk drug classes are evaluated in DRKS00017534's adverse drug event prevention model?
How does DRKS00017534's stewardship approach address polypharmacy challenges in medication safety optimization?